Epidemiology, characteristics, and outcomes of adult haemophagocytic lymphohistiocytosis in the USA, 2006–19: a national, retrospective cohort study

[1]  A. Belot,et al.  Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases , 2022, Journal of clinical medicine.

[2]  Ruoxi Zhang,et al.  A Study on Early Death Prognosis Model in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis , 2022, Journal of healthcare engineering.

[3]  Yu Wang,et al.  P1243: RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL , 2022, HemaSphere.

[4]  M. Bythell,et al.  Temporal Trends in the Incidence of Hemophagocytic Lymphohistiocytosis: A Nationwide Cohort Study From England 2003–2018 , 2022, medRxiv.

[5]  N. Poonit,et al.  Clinical Features and Prognostic Factors of Early Outcome in Pediatric Hemophagocytic Lymphohistiocytosis: A Retrospective Analysis of 227 Cases , 2021, Journal of pediatric hematology/oncology.

[6]  Laura Martin,et al.  PD32-09 SOCIOECONOMIC PREDICTORS OF RECEIVING A VAGINAL HYSTERECTOMY COMPARED TO OPEN AND LAPAROSCOPIC/ROBOTIC APPROACHES FOR TREATMENT OF APICAL PROLAPSE: AN ANALYSIS OF OVER 38,000 WOMEN IN THE HEALTHCARE COST AND UTILIZATION PROJECT (HCUP) , 2021 .

[7]  A. Manadan,et al.  Hemophagocytic Lymphohistiocytosis Hospitalizations in Adults and Its Association With Rheumatologic Diseases , 2020, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[8]  C. Spies,et al.  Treatment and Mortality of Hemophagocytic Lymphohistiocytosis in Adult Critically Ill Patients: A Systematic Review With Pooled Analysis , 2020, Critical care medicine.

[9]  C. Spies,et al.  Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore , 2020, Critical Care.

[10]  S. Nand,et al.  Hemophagocytic Lymphohistiocytosis in Adults: Associated Diagnoses and Outcomes, a Ten-Year Experience at a Single Institution , 2019, Journal of hematology.

[11]  N. Berliner,et al.  Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis. , 2019, Blood.

[12]  T. Staudinger,et al.  Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis , 2019, Journal of intensive care medicine.

[13]  V. Allareddy,et al.  Retrospective study of haemophagocytic syndrome hospitalisations in children in the USA , 2018, BMJ Paediatrics Open.

[14]  B. Kostov,et al.  Prognostic Factors of Death in 151 Adults With Hemophagocytic Syndrome: Etiopathogenically Driven Analysis , 2018, Mayo Clinic proceedings. Innovations, quality & outcomes.

[15]  S. Aleem,et al.  A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults , 2017, Journal of Clinical Immunology.

[16]  Yuanyuan Chen,et al.  Prognostic factors of early death in children with hemophagocytic lymphohistiocytosis , 2017, Cytokine.

[17]  D. Giustini,et al.  Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review. , 2016, Blood reviews.

[18]  A. Ferster,et al.  Performances of the H-Score for Diagnosis of Hemophagocytic Lymphohistiocytosis in Adult and Pediatric Patients. , 2016, American journal of clinical pathology.

[19]  Richard L. Amdur,et al.  Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial* , 2016, Critical care medicine.

[20]  C. Eby,et al.  Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis , 2015, American journal of hematology.

[21]  M. Sabel,et al.  Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden , 2015, Pediatric blood & cancer.

[22]  G. Hejblum,et al.  Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome , 2014, Arthritis & rheumatology.

[23]  M. George.  Hemophagocytic lymphohistiocytosis: review of etiologies and management , 2014, Journal of blood medicine.

[24]  A. López-Guillermo,et al.  Adult haemophagocytic syndrome , 2014, The Lancet.

[25]  C. Koriyama,et al.  Risk Factors for Early Fatal Outcomes Among Children with Hemophagocytic Lymphohistiocytosis (HLH): A Single-Institution Case-Series in Vietnam , 2014, Pediatric hematology and oncology.

[26]  A. Filipovich,et al.  Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab , 2013, Pediatric blood & cancer.

[27]  R. Egeler,et al.  Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. , 2011, Blood.

[28]  A. Filipovich,et al.  How I treat hemophagocytic lymphohistiocytosis. , 2011, Blood.

[29]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[30]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[31]  K. Kawa,et al.  Nationwide Survey of Hemophagocytic Lymphohistiocytosis in Japan , 2007, International journal of hematology.

[32]  M. Aricò,et al.  HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis , 2007, Pediatric blood & cancer.

[33]  M. Kato,et al.  Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[35]  A. Öst,et al.  Incidence in Sweden and Clinical Features of Familial Hemophagocytic Lymphohistiocytosis , 1991, Acta paediatrica Scandinavica.

[36]  Q. Zhang,et al.  Clinical features and outcomes in secondary adult hemophagocytic lymphohistiocytosis , 2018, QJM : monthly journal of the Association of Physicians.

[37]  Rascon.  [The National Cancer Institute]. , 1953, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.